Effectiveness and Outcome of Pulmonary Arterial Hypertension-Specific Therapy in Japanese Patients With Pulmonary Arterial Hypertension-Reference-Cited by-同舟云学术

Effectiveness and Outcome of Pulmonary Arterial Hypertension-Specific Therapy in Japanese Patients With Pulmonary Arterial Hypertension

Published:2018 Issue:1 Volume:82 Page:275-282
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Tamura Yuichi¹,Kumamaru Hiraku²,Satoh Toru³,Miyata Hiroaki²⁴,Ogawa Aiko⁵,Tanabe Nobuhiro⁶,Hatano Masaru⁷,Yao Atsushi⁸,Abe Kohtaro⁹,Tsujino Ichizo¹⁰,Fukuda Keiichi¹¹,Kimura Hiroshi¹²,Kuwana Masataka¹³,Matsubara Hiromi⁵,Tatsumi Koichiro¹⁴,

Affiliation:

1. Pulmonary Hypertension Center, International University of Health and Welfare Mita Hospital

2. Department of Healthcare Quality Assessment, Graduate School of Medicine, The University of Tokyo

3. Department of Cardiology, Kyorin University School of Medicine

4. Department of Health Policy and Management, Keio University School of Medicine

5. Department of Clinical Science, National Hospital Organization Okayama Medical Center

6. Department of Advanced Medicine in Pulmonary Hypertension, Graduate School of Medicine, Chiba University

7. Department of Cardiology, The University of Tokyo Hospital

8. Division for Health Service Promotion, The University of Tokyo

9. Department of Cardiovascular Medicine, Kyushu University Hospital

10. First Department of Medicine, Hokkaido University School of Medicine

11. Department of Cardiology, Keio University School of Medicine

12. Second Department of Internal Medicine, Nara Medical University

13. Department of Allergy and Rheumatology, Nippon Medical School Graduate School of Medicine

14. Department of Respirology, Graduate School of Medicine, Chiba University

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/circj/82/1/82_CJ-17-0139/_pdf

Reference18 articles.

1. 1. Galiè N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, et al. 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Respir J 2015; 46: 903–975.

2. 2. Wilkins MR. Pulmonary hypertension: The science behind the disease spectrum. Eur Respir Rev 2012; 21: 19–26.

3. 3. Humbert M, Sitbon O, Chaouat A, Bertocchi M, Habib G, Gressin V, et al. Pulmonary arterial hypertension in France: Results from a national registry. Am J Respir Crit Care Med 2006; 173: 1023–1030.

4. 4. Peacock AJ, Murphy NF, McMurray JJ, Caballero L, Stewart S. An epidemiological study of pulmonary arterial hypertension. Eur Respir J 2007; 30: 104–109.

5. 5. Frost AE, Badesch DB, Barst RJ, Benza RL, Elliott CG, Farber HW, et al. The changing picture of patients with pulmonary arterial hypertension in the United States: How REVEAL differs from historic and non-US contemporary registries. Chest 2011; 139: 128–137.

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Selexipag for patients with pulmonary hypertension associated with lung disease: A preliminary study;Respiratory Investigation;2024-09

2. Total bile acids levels as a stratification tool for screening portopulmonary hypertension in patients with decompensated cirrhosis;Hepatology Research;2024-05-23

3. Management of pulmonary hemodynamics prior to delivery in a pregnant woman with development of decompensated pulmonary arterial hypertension;Journal of Cardiology Cases;2024-02

4. Long-term efficacies of selective vasodilators in pulmonary arterial hypertension: a comprehensive comparison using a spontaneous reporting database;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-01-05

5. Prognostic analysis of pulmonary hypertension with lung parenchymal lesion: Comparison of mortality with and without connective tissue disease;Respiratory Investigation;2024-01